Fund profile
Fund manager
Total assets
$10.62 mm
Liabilities
$260.14 k
Net assets
$10.36 mm
Number of holdings
44.00
44 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
OGN Organon & Co. | 540.66 k | 37.49 k shares | 5.22 | Common equity | Long | USA |
CTLT Catalent Inc. | 499.31 k | 11.11 k shares | 4.82 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 490.88 k | 6.85 k shares | 4.74 | Common equity | Long | USA |
ELAN Elanco Animal Health Inc | 480.97 k | 32.28 k shares | 4.64 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 468.71 k | 5.89 k shares | 4.52 | Common equity | Long | USA |
VTRS Viatris Inc | 455.24 k | 42.04 k shares | 4.39 | Common equity | Long | USA |
PRGO Perrigo Company plc | 448.43 k | 13.94 k shares | 4.33 | Common equity | Long | Ireland |
ZTS Zoetis Inc - Ordinary Shares | 441.91 k | 2.24 k shares | 4.26 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 439.05 k | 18.59 k shares | 4.24 | Common equity | Long | USA |
MRK Merck & Co Inc | 434.23 k | 3.98 k shares | 4.19 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 422.01 k | 3.43 k shares | 4.07 | Common equity | Long | Ireland |
BMY Bristol-Myers Squibb Co. | 421.46 k | 8.21 k shares | 4.07 | Common equity | Long | USA |
JNJ Johnson & Johnson | 419.44 k | 2.68 k shares | 4.05 | Common equity | Long | USA |
PFE Pfizer Inc. | 413.34 k | 14.36 k shares | 3.99 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 406.27 k | 14.46 k shares | 3.92 | Common equity | Long | UK |
LLY Lilly(Eli) & Co | 402.80 k | 691.00 shares | 3.89 | Common equity | Long | USA |
CORT Corcept Therapeutics Inc | 275.50 k | 8.48 k shares | 2.66 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 272.00 k | 18.48 k shares | 2.63 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 253.41 k | 28.83 k shares | 2.45 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 240.28 k | 7.44 k shares | 2.32 | Common equity | Long | USA |
Invesco Government & Agency Portfolio | 229.48 k | 229.48 k shares | 2.21 | Short-term investment vehicle | N/A | USA |
AMPH Amphastar Pharmaceuticals Inc | 226.49 k | 3.66 k shares | 2.19 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 209.36 k | 6.21 k shares | 2.02 | Common equity | Long | USA |
SAVA Cassava Sciences Inc | 191.90 k | 8.53 k shares | 1.85 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc | 169.70 k | 2.77 k shares | 1.64 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals Inc | 145.37 k | 5.02 k shares | 1.40 | Common equity | Long | USA |
ARVN Arvinas Inc | 125.83 k | 3.06 k shares | 1.21 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 121.34 k | 6.70 k shares | 1.17 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals Inc | 117.56 k | 2.13 k shares | 1.13 | Common equity | Long | USA |
INVA Innoviva Inc | 109.52 k | 6.83 k shares | 1.06 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 103.38 k | 5.11 k shares | 1.00 | Common equity | Long | USA |
HSBC SECURITIES USA INC | 90.00 k | 90.00 k principal | 0.87 | Repurchase agreement | Long | USA |
COLL Collegium Pharmaceutical Inc | 87.42 k | 2.84 k shares | 0.84 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 80.49 k | 1.13 k shares | 0.78 | Common equity | Long | USA |
AMRX Amneal Pharmaceuticals Inc - Ordinary Shares | 72.18 k | 11.89 k shares | 0.70 | Common equity | Long | USA |
SOCIETE GENERALE | 72.00 k | 72.00 k principal | 0.69 | Repurchase agreement | Long | USA |
EOLS Evolus Inc | 51.99 k | 4.94 k shares | 0.50 | Common equity | Long | USA |
TBPH Theravance Biopharma Inc | 50.31 k | 4.48 k shares | 0.49 | Common equity | Long | Cayman Islands |
ROYAL BANK OF CANADA | 28.00 k | 28.00 k principal | 0.27 | Repurchase agreement | Long | USA |
CREDIT AGRICOLE CIB NY | 28.00 k | 28.00 k principal | 0.27 | Repurchase agreement | Long | USA |
NATWEST MARKETS PLC | 28.00 k | 28.00 k principal | 0.27 | Repurchase agreement | Long | USA |
UMB FINANCIAL CORP | 12.00 k | 12.00 k principal | 0.12 | Repurchase agreement | Long | USA |
CASSAVA SCIENCES INC | 2.66 k | 3.48 k shares | 0.03 | Equity derivative | N/A | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX
GOLDMAN SACHS GROUP, INC
|
1.47 k | 18.00 other units | 0.01 | Equity derivative | N/A | USA |